| ADGRV1 altered in cohorts of …ALTERED_INderived23 of 23show fewer |
|---|
| → altered in cohorts of | Skin Basal Cell Carcinoma 82 / 126 cases (65 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 166 / 469 cases (35 %) · ssm · skcm_tcga_gdc · largest of 8 cohorts | — | — | Cutaneous Melanoma | 8 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 43 / 144 cases (30 %) · ssm · mel_dfci_2019 · largest of 2 cohorts | — | — | Melanoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 20 / 83 cases (24 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 34 / 158 cases (22 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 86 / 517 cases (17 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 80 / 484 cases (17 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Lung Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 65 / 429 cases (15 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Invasive Breast Carcinoma 20 / 134 cases (15 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Endometrioid Adenocarcinoma 35 / 247 cases (14 %) · ssm · uec_cptac_gdc | — | — | Endometrial Endometrioid Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 147 / 1,144 cases (13 %) · ssm · nsclc_tcga_broad_2016 | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 65 / 518 cases (13 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 22 / 185 cases (12 %) · ssm · esca_tcga | — | — | Esophageal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 53 / 478 cases (11 %) · ssm · stad_tcga · largest of 4 cohorts | — | — | Gastric Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 30 / 291 cases (10 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 3 cohorts | — | — | Cervical Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinoma 55 / 566 cases (9.7 %) · ssm · luad_tcga_pan_can_atlas_2018 | — | — | Lung Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 47 / 494 cases (9.5 %) · ssm · hcc_clca_2024 · largest of 5 cohorts | — | — | Hepatocellular Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Diffuse Glioma 58 / 629 cases (9.2 %) · ssm · difg_glass · largest of 2 cohorts | — | — | Diffuse Glioma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 36 / 474 cases (7.6 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 39 / 515 cases (7.6 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 72 / 1,015 cases (7.1 %) · ssm · crc_sysucc_2022 · largest of 2 cohorts | — | — | Colorectal Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 21 / 297 cases (7.1 %) · ssm · mbn_sfu_2023 | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 24 / 417 cases (5.8 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |